4.6 Article

Prefrontal tDCS modulates autonomic responses in COVID-19 inpatients

Journal

BRAIN STIMULATION
Volume 16, Issue 2, Pages 657-666

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.brs.2023.03.001

Keywords

COVID-19; Transcranial direct current stimulation; Safety and feasibility; Autonomic nervous system; Heart rate variability

Ask authors/readers for more resources

The study aimed to investigate the efficacy, safety, and feasibility of a single session of bihemispheric prefrontal tDCS on cardiac autonomic regulation and mood of COVID-19 inpatients. The results showed a significant effect of tDCS on cardiac autonomic regulation, with increased oxygen saturation in the active group. However, no significant differences were observed in mood and adverse effects. Therefore, a single prefrontal tDCS session is safe and effective in modulating cardiac autonomic regulation in acute COVID-19 inpatients.
Background: maladaptive changes in the autonomic nervous system (ANS) have been observed in short and long-term phases of COVID-19 infection. Identifying effective treatments to modulate autonomic imbalance could be a strategy for preventing and reducing disease severity and induced complications. Objective: to investigate the efficacy, safety, and feasibility of a single session of bihemispheric prefrontal tDCS on indicators of cardiac autonomic regulation and mood of COVID-19 inpatients. Methods: patients were randomized to receive a single 30-min session of bihemispheric active tDCS over the dorsolateral prefrontal cortex (2 mA; n = 20) or sham (n = 20). Changes in time [post-pre inter-vention] in heart rate variability (HRV), mood, heart rate, respiratory rate, and oxygen saturation were compared between groups. Additionally, clinical worsening indicators and the occurrence of falls and skin injuries were evaluated. The Brunoni Adverse Effects Questionary was employed after the intervention. Results: there was a large effect size (Hedges' g = 0.7) of intervention on HRV frequency parameters, suggesting alterations in cardiac autonomic regulation. An increment in oxygen saturation was observed in the active group but not in the sham after the intervention (P = 0.045). There were no group dif-ferences regarding mood, incidence and intensity of adverse effects, no occurrence of skin lesions, falls, or clinical worsening. Conclusions: a single prefrontal tDCS session is safe and feasible to modulate indicators of cardiac autonomic regulation in acute COVID-19 inpatients. Further research comprising a thorough assessment of autonomic function and inflammatory biomarkers is required to verify its potential to manage autonomic dysfunctions, mitigate inflammatory responses and enhance clinical outcomes. (c) 2023 The Authors. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available